Victory Capital Management Inc. Has $308,000 Stake in Sotera Health (NASDAQ:SHC)

Victory Capital Management Inc. grew its stake in Sotera Health (NASDAQ:SHC) by 25.4% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 25,944 shares of the company’s stock after purchasing an additional 5,258 shares during the period. Victory Capital Management Inc.’s holdings in Sotera Health were worth $308,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. CWM LLC boosted its position in Sotera Health by 86.1% in the second quarter. CWM LLC now owns 2,146 shares of the company’s stock valued at $25,000 after buying an additional 993 shares in the last quarter. Swiss National Bank boosted its holdings in shares of Sotera Health by 0.5% during the 1st quarter. Swiss National Bank now owns 195,900 shares of the company’s stock valued at $2,353,000 after acquiring an additional 1,000 shares in the last quarter. TD Asset Management Inc grew its position in Sotera Health by 1.5% during the 2nd quarter. TD Asset Management Inc now owns 123,454 shares of the company’s stock worth $1,465,000 after acquiring an additional 1,800 shares during the last quarter. Securian Asset Management Inc. increased its holdings in Sotera Health by 23.0% in the 1st quarter. Securian Asset Management Inc. now owns 10,178 shares of the company’s stock worth $122,000 after purchasing an additional 1,900 shares in the last quarter. Finally, State of Alaska Department of Revenue raised its position in Sotera Health by 20.6% in the first quarter. State of Alaska Department of Revenue now owns 13,490 shares of the company’s stock valued at $162,000 after purchasing an additional 2,300 shares during the last quarter. 91.03% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on SHC shares. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $17.00 price objective on shares of Sotera Health in a research note on Tuesday, August 6th. Barclays raised their price target on shares of Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a research note on Tuesday, August 6th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $15.70.

Sotera Health Price Performance

Shares of NASDAQ SHC opened at $16.64 on Tuesday. The company has a quick ratio of 2.59, a current ratio of 2.93 and a debt-to-equity ratio of 5.46. The company has a market capitalization of $4.71 billion, a PE ratio of 87.58 and a beta of 2.07. The firm has a fifty day simple moving average of $14.96 and a 200 day simple moving average of $12.86. Sotera Health has a twelve month low of $10.71 and a twelve month high of $17.44.

Sotera Health (NASDAQ:SHC) last announced its earnings results on Monday, August 5th. The company reported $0.19 EPS for the quarter, beating the consensus estimate of $0.15 by $0.04. The company had revenue of $277.00 million for the quarter, compared to analyst estimates of $266.45 million. Sotera Health had a return on equity of 47.26% and a net margin of 3.65%. The firm’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.19 EPS. On average, sell-side analysts forecast that Sotera Health will post 0.64 EPS for the current year.

Insider Activity at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock in a transaction on Friday, September 6th. The shares were sold at an average price of $15.03, for a total value of $150,300,000.00. Following the completion of the sale, the director now directly owns 49,215,301 shares of the company’s stock, valued at $739,705,974.03. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 55.12% of the stock is owned by corporate insiders.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.